MELAS syndrome and risk of infection

Muskaan Saleem , Myra Sohail , Ahmad Akhtar

Emergency and Critical Care Medicine ›› 2025, Vol. 5 ›› Issue (3) : 121 -122.

PDF (75KB)
Emergency and Critical Care Medicine ›› 2025, Vol. 5 ›› Issue (3) :121 -122. DOI: 10.1097/EC9.0000000000000130
Perspective/Viewpoint
research-article
MELAS syndrome and risk of infection
Author information +
History +
PDF (75KB)

Cite this article

Download citation ▾
Muskaan Saleem, Myra Sohail, Ahmad Akhtar. MELAS syndrome and risk of infection. Emergency and Critical Care Medicine, 2025, 5(3): 121-122 DOI:10.1097/EC9.0000000000000130

登录浏览全文

4963

注册一个新账户 忘记密码

Conflict of interest statement

The authors declare no conflict of interest.

Author contributions

All 3 authors participated in the writing of the paper.

Funding

None.

Ethical approval of studies and informed consent

Not applicable.

Acknowledgments

None.

References

[1]

El-Hattab AW, Adesina AM, Jones J, Scaglia F. MELAS syndrome: clinical manifestations, pathogenesis, and treatment options. Mol Genet Metab. 2015; 116(1-2):4-12. doi:10.1016/j.ymgme.2015.06.004

[2]

Faas MM, De Vos P. Mitochondrial function in immune cells in health and disease. Biochim Biophys Acta Mol Basis Dis. 1866; 2020(10): 165845. doi:10.1016/j.bbadis.2020.165845

[3]

Iborra-Pernichi M, Ruiz García J, Velasco de la Esperanza M, et al. Defective mitochondria remodelling in B cells leads to an aged immune response. Nat Commun. 2024; 15(1):2569. doi:10.1038/s41467-024-46763-1

[4]

Shimotake T, Furukawa T, Inoue K, Iwai N, Takeuchi Y. Familial occurrence of intestinal obstruction in children with the syndrome of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS). J Pediatr Surg. 1998; 33(12):1837-1839. doi:10.1016/s0022-3468(98)90301-3

[5]

Pia S, Lui F. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing. Accessed March 15, 2024. https://www.ncbi.nlm.nih.gov/books/NBK532959/#article-24940.s4

[6]

Weinberg SE, Sena LA, Chandel NS. Mitochondria in the regulation of innate and adaptive immunity. Immunity. 2015; 42(3):406-417. doi:10.1016/j.immuni.2015.02.002

[7]

McKee DH, Cooper PN, Denning DW. Invasive aspergillosis in a patient with MELAS syndrome. J Neurol Neurosurg Psychiatry. 2000; 68(6):765-767. doi:10.1136/jnnp.68.6.765

[8]

Kunst C, Schmid S, Michalski M, et al. The influence of gut microbiota on oxidative stress and the immune system. Biomedicine. 2023; 11(5):1388. doi:10.3390/biomedicines11051388

[9]

Hussain Y, Khan H. Immunosuppressive drugs. In: Encyclopedia of Infection and Immunity. Amsterdam, Netherlands: Elsevier; 2022;(4):726-740. Accessed March 15, 2024. https://www.sciencedirect.com/science/article/abs/pii/B9780128187319000689?via%3Dihub

[10]

Sen K, Harrar D, Hahn A, Wells EM, Gropman AL. Management considerations for stroke-like episodes in MELAS with concurrent COVID-19 infection. J Neurol. 2021; 268(11):3988-3991. doi:10.1007/s00415-021-10538-1

PDF (75KB)

6

Accesses

0

Citation

Detail

Sections
Recommended

/